knowledge center

Mira for perimenopause

Most common use cases

Protocols

PROTOCOL

Perimenopause

Mira tracks hormones in perimenopause for personalized, effective treatment timing.

DOWNLOAD

Case reports

ESTROGEN DOMINANCE

Mira assisting in clinical
evaluation and treatment
Case Report with BiOrigin:
Perimenopause

POST-HYSTERECTOMY | PMDD

Hysterectomy PMDD cyclic progesterone

POST-HYSTERECTOMY

Post-hysterectomy hormone tracking with Mira used correlate symptoms and time interventions

MENORRHAGIA

Perimenopause menorrhagia IUD

PMDD

Perimenopause with PMDD

Webinars

WEBINAR-1
WEBINAR

Utilizing Mira with NFP/FABM including hormonal imbalances and disruptions, postpartum amenorrhea, PCOS, and perimenopause case reports

Using the Mira fertility monitor in fertility awareness-based methods, highlighting its personalized hormone tracking capabilities, applications in different reproductive stages, and practical case studies for educators and healthcare providers.

Watch here
WEBINAR-1
WEBINAR

Using Mira with fertility awareness-based methods or natural family planning.

Webinar on how Mira's hormone tracking improves patient outcomes, enhancing engagement and empowering treatment decisions across fertility, reproductive health, and personalized care. With Dr. Stephanie Hayes.

Watch here
Screenshot 2024-10-14 at 17.51.46
WEBINAR

A Woman’s Cycle of Life: Maximizing Outcomes through Mira and Femmenessence

This webinar focuses on understanding women's hormonal needs throughout life, expanding clinical tools for personalized care, using Mira for fertility support, and balancing hormones with Femmenessence for optimal health outcomes.

Watch here

Chart examples

Screenshot 2024-10-15 at 12.16.49

[Estrogen dominance] Patient identifies ovulatory vs anovulatory cycles.
In this example, we have a 49-year-old female patient who had been experiencing severe cycle
variability alongside heavy bleeding and many days of spotting. Sometimes her cycles were
long, but other times they were short. At times, the patient was unsure if she was having
breakthrough bleeding or true ovulatory cycles.
The patient began testing with Mira, which revealed an underlying hormone pattern.


Mira Data Discovered: Consistently elevated E3G, Lack of LH surge and Lack of PdG changes
Provider identified estrogen dominance and anovulatory cycle.


By discovering her underlying hormone patterns, she could identify ovulatory vs. anovulatory
cycles and discuss potential treatment options with her provider

Screenshot 2024-10-15 at 12.15.16

[Part 1 - Estrogen dominance] In another case, a 50-year-old female was diagnosed with perimenopause, stress, anxiety, HPA axis dysfunction, endometriosis, and adenomyosis.

Patient identifies anovulatory cycles and estrogen dominance.
She had experienced a stressful year with multiple life stressors and traumatic events; living in a
crisis state of anxiety, depression, and suicidal thoughts. She also experienced heavy periods,
breast tenderness, losing her hair, and a significant decline in mood. 


Before treatment. Mira data discovered: Fluctuating and high estrogen levels, Lack of LH surge, Lack of progesterone changes

Screenshot 2024-10-15 at 12.16.02

[part 2 - Estrogen dominance] After hormone replacement therapy (HRT) treatment.

 
After hormone monitoring with Mira, her provider observed estrogen fluctuations and peaks -
without an LH surge or progesterone changes. They also found a correlation between irritability
and mood changes related to estrogen peaks.
Her provider determined that she was experiencing estrogen dominance and anovulatory
cycles. Treatment was a combination of lifestyle, diet, supplement modifications, and the use of
topical transdermal progesterone.
 
Mira data discovered:
● Improved estrogen levels and pattern
● Continued low LH
● Minimal PdG changes
● Anovulatory cycle
 
Following HRT, the provider was able to see an improvement in estrogen patterns. Many of the
patient’s symptoms also eased, and her understanding of what was going on in her body
improved - providing her with a huge sense of relief.
 
 
 
 
 
 
 
 
Screenshot 2024-10-15 at 12.23.01

[Abnormal Hormone Pattern]
Problem:
• Unable to identify
ovulation
• Unable to determine
fertile vs infertile days

Mira data discovered:
• Uncoordinated hormone
pattern
• Lack of LH surge

Screenshot 2024-10-15 at 12.23.01-1
[Abnormal Hormone Pattern] Mira data discovered:
• Rising E3G levels approaching
LH surge
• LH surge on CD 18
• Elevated PdG after LH surge
confirming ovulation
 
Outcome:
• Hormones normalized after
stopping spironolactone
• The patient was thrilled
to be able to identify her
fertile window to avoid
a pregnancy
Screenshot 2024-10-15 at 12.25.16
[Progesterone oral use] Progesterone supplementation example
Mira data discovered:
- Sustained elevated PdG levels
- PdG levels at max threshold of 30
 

Discover our most common use cases

Got specific questions?

Read our Frequently Asked Questions here, or schedule a meeting with our Medical Affairs Specialist Rose
for support with integrating Mira into your practice and interpreting patients' charts.